Furthermore, it has been demonstrated in several in vitro and in vivo prostate cancer models, including LNCaP expressing mutated or wild type AR, that radiation therapy can upregulate AR signaling in CRPC leading to radioresistance [20]. The gene discussed is AR; the disease is prostate cancer.